{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:25:41Z","timestamp":1793334341423,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T00:00:00Z","timestamp":1424822400000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["RR02305"],"award-info":[{"award-number":["RR02305"]}]},{"name":"Pennsylvania State Tobacco Settlement","award":["SAP4100027296"],"award-info":[{"award-number":["SAP4100027296"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/j.nicl.2015.02.016","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T14:19:29Z","timestamp":1424960369000},"page":"598-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Mohammad","family":"Haris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ena","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias R.","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijitt","family":"Borthakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nicl.2015.02.016_ref1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.nicl.2015.02.016_ref2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15622970310029912","article-title":"CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42","volume":"4","author":"Andreasen","year":"2003","journal-title":"World J. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/bbrc.1997.6908","article-title":"Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology","volume":"236","author":"Arai","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.nicl.2015.02.016_ref4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0730-725X(99)00041-7","article-title":"3D spin-lock imaging of human gliomas","volume":"17","author":"Aronen","year":"1999","journal-title":"Magn. Reson. Imaging"},{"issue":"6","key":"10.1016\/j.nicl.2015.02.016_ref5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.52.6.1153","article-title":"Medial temporal lobe atrophy on MRI in dementia with Lewy bodies","volume":"52","author":"Barber","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2015.02.016_ref6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2004.01368.x","article-title":"CSF biomarkers for mild cognitive impairment","volume":"256","author":"Blennow","year":"2004","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jmri.20751","article-title":"In vivo measurement of plaque burden in a mouse model of Alzheimer's disease","volume":"24","author":"Borthakur","year":"2006","journal-title":"J. Magn. Reson. Imaging"},{"issue":"7","key":"10.1016\/j.nicl.2015.02.016_ref8","first-page":"781","article-title":"Sodium and T1rho MRI for molecular and diagnostic imaging of articular cartilage","volume":"19","author":"Borthakur","year":"2006","journal-title":"N.M.R. Biomed."},{"issue":"4","key":"10.1016\/j.nicl.2015.02.016_ref9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuroimage.2008.03.030","article-title":"T1rho MRI of Alzheimer's disease","volume":"41","author":"Borthakur","year":"2008","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.nicl.2015.02.016_ref10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jmri.20016","article-title":"In vivo measurement of T1rho dispersion in the human brain at 1.5\u00a0Tesla","volume":"19","author":"Borthakur","year":"2004","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2015.02.016_ref11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-60761-744-0_13","article-title":"Selecting a mouse model of Alzheimer's disease","volume":"670","author":"Chin","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.neuroimage.2011.05.083","article-title":"Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease","volume":"58","author":"Chincarini","year":"2011","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.nicl.2015.02.016_ref13","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.neurobiolaging.2013.02.002","article-title":"Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment","volume":"34","author":"Clerx","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.nicl.2015.02.016_ref14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0197-4580(00)00183-4","article-title":"Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis","volume":"21","author":"Cummings","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nicl.2015.02.016_ref15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neurobiolaging.2006.11.010","article-title":"Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging","volume":"29","author":"Davatzikos","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nicl.2015.02.016_ref16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2796.2004.01381.x","article-title":"MRI and CSF studies in the early diagnosis of Alzheimer's disease","volume":"256","author":"de Leon","year":"2004","journal-title":"J. Intern. Med."},{"issue":"24","key":"10.1016\/j.nicl.2015.02.016_ref17","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1212\/01.wnl.0000336925.79704.9f","article-title":"Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease","volume":"71","author":"Duara","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nicl.2015.02.016_ref18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/msj.20159","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"77","author":"Elder","year":"2010","journal-title":"Mt Sinai J. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.nicl.2015.02.016_ref19","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3233\/JAD-2011-111292","article-title":"Magnetic resonance imaging based clinical research in Alzheimer's disease","volume":"31","author":"Fayed","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.nicl.2015.02.016_ref21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.31887\/DCNS.2004.6.4\/hhampel","article-title":"CSF tau and beta-amyloid as biomarkers for mild cognitive impairment","volume":"6","author":"Hampel","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archneur.62.5.770","article-title":"Correlation of cerebrospinal fluid levels of Tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease","volume":"62","author":"Hampel","year":"2005","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.nicl.2015.02.016_ref23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref24","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1111\/j.1552-6569.2010.00467.x","article-title":"T(1\u03c1) MRI in Alzheimer's disease: detection of pathological changes in medial temporal lobe","volume":"21","author":"Haris","year":"2011","journal-title":"J. Neuroimaging"},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref25","first-page":"83","article-title":"Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances","volume":"13","author":"Harwood","year":"2000","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"issue":"1","key":"10.1016\/j.nicl.2015.02.016_ref26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-2008-14105","article-title":"CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy","volume":"14","author":"Herukka","year":"2008","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.nicl.2015.02.016_ref27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2015.02.016_ref28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1212\/WNL.49.3.786","article-title":"Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease","volume":"49","author":"Jack","year":"1997","journal-title":"Neurol."},{"issue":"1","key":"10.1016\/j.nicl.2015.02.016_ref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.06.015","article-title":"Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease","volume":"33","author":"Kadir","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.nicl.2015.02.016_ref30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/JGP.0b013e3182358921","article-title":"Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis","volume":"20","author":"Koppel","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nicl.2015.02.016_ref31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4419-7756-4_19","article-title":"Characterizing breast cancer mouse xenografts with T(1)rho -MRI: a preliminary study","volume":"701","author":"Li","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.nicl.2015.02.016_ref32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.nicl.2015.02.016_ref33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.54.5.1099","article-title":"Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"54","author":"Otto","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nicl.2015.02.016_ref35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100720170055","article-title":"CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group","volume":"22","author":"Parnetti","year":"2001","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nicl.2015.02.016_ref36","article-title":"Amyloid-beta positron emission tomography in the diagnostic evaluation of Alzheimer disease: summary of primary findings and conclusions","author":"Pearson","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"12","key":"10.1016\/j.nicl.2015.02.016_ref37","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.nicl.2015.02.016_ref38","first-page":"741","article-title":"3D-T1rho-relaxation mapping of articular cartilage: in vivo assessment of early degenerative changes in symptomatic osteoarthritic subjects","volume":"11","author":"Regatte","year":"2004","journal-title":"Acad. Radiol."},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1373\/clinchem.2006.081679","article-title":"Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid beta(42) and tau proteins","volume":"53","author":"Reijn","year":"2007","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.nicl.2015.02.016_ref40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002541","article-title":"MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study","volume":"3","author":"Richard","year":"2013","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.nicl.2015.02.016_ref41","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref42","doi-asserted-by":"crossref","first-page":"e97486","DOI":"10.1371\/journal.pone.0097486","article-title":"High resolution T1rho mapping of in vivo human knee cartilage at 7T","volume":"9","author":"Singh","year":"2014","journal-title":"PLOS One"},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.neurobiolaging.2008.06.016","article-title":"Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study","volume":"31","author":"Sluimer","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/01.WNL.0000153070.82309.D4","article-title":"Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies","volume":"64","author":"Tam","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nicl.2015.02.016_ref45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(00)00480-9","article-title":"Diagnostic significance of Tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy","volume":"183","author":"Urakami","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.nicl.2015.02.016_ref46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","article-title":"Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's biomarkers Standardization Initiative","volume":"8","author":"Vanderstichele","year":"2012","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.0b013e3181e7ca82","article-title":"Serial MRI and CSF biomarkers in normal aging, MCI, and AD","volume":"75","author":"Vemuri","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2015.02.016_ref48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jmri.24358","article-title":"In vivo whole-brain T1-rho mapping across adulthood: normative values and age dependence","volume":"40","author":"Watts","year":"2014","journal-title":"J. Magn. Reson. Imaging"},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref49","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/mrm.20678","article-title":"Quantification of cartilage biomechanical and biochemical properties via T1rho magnetic resonance imaging","volume":"54","author":"Wheaton","year":"2005","journal-title":"Magn. Reson. Med."},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ana.10661","article-title":"Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease","volume":"54","author":"Wiltfang","year":"2003","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2015.02.016_ref51","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/mrm.22272","article-title":"T1rho MRI quantification of arthroscopically confirmed cartilage degeneration","volume":"63","author":"Witschey","year":"2010","journal-title":"Magn. Reson. Med."},{"issue":"2","key":"10.1016\/j.nicl.2015.02.016_ref52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1742-1241.2011.02845.x","article-title":"Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment","volume":"66","author":"Zhang","year":"2012","journal-title":"Int. J. Clin. Pract."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158215000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158215000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:07:44Z","timestamp":1761970064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158215000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":52,"alternative-id":["S2213158215000340"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2015.02.016","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2015.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}